Selective Serotonin Reuptake Inhibitors: A New Modality for the Treatment of Lymphoma/Leukaemia?

BMC Pharmacology
doi 10.1186/1471-2210-7-s2-a8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search